Pediatric brain tumors: innovative genomic information is transforming the diagnostic and clinical landscape
A Gajjar, DC Bowers, MA Karajannis… - Journal of Clinical …, 2015 - ascopubs.org
Pediatric neuro-oncology has undergone an exciting and dramatic transformation during the
past 5 years. This article summarizes data from collaborative group and institutional trials …
past 5 years. This article summarizes data from collaborative group and institutional trials …
[HTML][HTML] Cellular commitment in the developing cerebellum
The mammalian cerebellum is located in the posterior cranial fossa and is critical for motor
coordination and non-motor functions including cognitive and emotional processes. The …
coordination and non-motor functions including cognitive and emotional processes. The …
Unified rhombic lip origins of group 3 and group 4 medulloblastoma
KS Smith, L Bihannic, BL Gudenas, P Haldipur, R Tao… - Nature, 2022 - nature.com
Medulloblastoma, a malignant childhood cerebellar tumour, segregates molecularly into
biologically distinct subgroups, suggesting that a personalized approach to therapy would …
biologically distinct subgroups, suggesting that a personalized approach to therapy would …
Resolving medulloblastoma cellular architecture by single-cell genomics
Medulloblastoma is a malignant childhood cerebellar tumour type that comprises distinct
molecular subgroups. Whereas genomic characteristics of these subgroups are well …
molecular subgroups. Whereas genomic characteristics of these subgroups are well …
Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord
Cell-free DNA shed by cancer cells has been shown to be a rich source of putative tumor-
specific biomarkers. Because cell-free DNA from brain and spinal cord tumors cannot …
specific biomarkers. Because cell-free DNA from brain and spinal cord tumors cannot …
[HTML][HTML] Medulloblastoma genotype dictates blood brain barrier phenotype
TN Phoenix, DM Patmore, S Boop, N Boulos, MO Jacus… - Cancer cell, 2016 - cell.com
The childhood brain tumor, medulloblastoma, includes four subtypes with very different
prognoses. Here, we show that paracrine signals driven by mutant β-catenin in WNT …
prognoses. Here, we show that paracrine signals driven by mutant β-catenin in WNT …
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial
GW Robinson, VA Rudneva, I Buchhalter… - The Lancet …, 2018 - thelancet.com
Background Young children with medulloblastoma have a poor overall survival compared
with older children, due to use of radiation-sparing therapy in young children. Radiotherapy …
with older children, due to use of radiation-sparing therapy in young children. Radiotherapy …
Childhood medulloblastoma
M Massimino, V Biassoni, L Gandola, ML Garrè… - Critical reviews in …, 2016 - Elsevier
Abstract Medulloblastoma accounts for 15–20% of childhood nervous system tumours. The
risk of dying was reduced by 30% in the last twenty years. Patients are divided in risk strata …
risk of dying was reduced by 30% in the last twenty years. Patients are divided in risk strata …
[HTML][HTML] Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor
GW Robinson, SC Kaste, W Chemaitilly, DC Bowers… - Oncotarget, 2017 - ncbi.nlm.nih.gov
The permanent defects in bone growth observed in preclinical studies of hedgehog (Hh)
pathway inhibitors were not substantiated in early phase clinical studies of vismodegib in …
pathway inhibitors were not substantiated in early phase clinical studies of vismodegib in …
Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy
C Cacciotti, A Fleming… - The Journal of pathology, 2020 - Wiley Online Library
Central nervous system (CNS) tumors are the most common solid tumor in pediatrics,
accounting for approximately 25% of all childhood cancers, and the second most common …
accounting for approximately 25% of all childhood cancers, and the second most common …